Choosing the Right Form of Magnesium: A Clinician’s Guide to Forms, Bioavailability, and Clinical Fit

Written by Dr Malisa Carullo, ND, MSc

Magnesium participates in more than 600 enzymatic reactions in the body, from ATP synthesis and DNA repair to muscle contraction, neurotransmitter regulation, and blood glucose control.¹Despite its central role, surveys consistently show that more than half of Americans do not meet their estimated average requirement from diet alone.²

That gap has driven a surge in magnesium supplementation, and along with it, a genuinely confusing supplement aisle. Magnesium oxide, glycinate, citrate, malate, L-threonate, taurate, chloride: the list goes on. Many products lead on bioavailability, positioning their formula as the best absorbed form of magnesium available, which can be misleading. Absorption is one important variable, but it is not the only factor that determines clinical outcomes.

From a clinical standpoint, the more useful question is not which form has the highest bioavailability, but rather which form is right for this person’s physiology, health goals, and clinical presentation.

This guide breaks down how magnesium forms differ in bioavailability and function, and how to match the right form to the right therapeutic goal.

Why Magnesium Form Matters

Elemental magnesium is never found in isolation. It is always bound to something. In food, it is bound to proteins and other molecules. In supplements, manufacturers bind it to a carrier compound that determines the product’s name, stability, solubility, and ultimately its absorption characteristics.

Three factors determine how much magnesium from a supplement reaches systemic circulation:

Solubility: how readily the compound dissolves in the gut

Chemistry (organic vs. inorganic): whether the carrier contains carbon, which affects dissolution kinetics

Chelation: whether magnesium is bound to an amino acid, enabling absorption through alternative intestinal transporters

Organic vs. Inorganic Forms

In supplement chemistry, the term “organic” simply means the carrier compound contains carbon. It has nothing to do with farming or food labeling. Organic forms such as glycinate, citrate, malate, taurate, and L-threonate dissolve more readily in the gastrointestinal tract and do not require high levels of stomach acid to ionize.⁵ Inorganic forms such as oxide and sulfate rely more on stomach acid for dissolution, making their absorption more variable and particularly less predictable in individuals with hypochlorhydria, a common finding in older adults and those on long-term proton pump inhibitors.

Clinical Note: More Elemental Magnesium Does Not Equal More Absorbed

Magnesium oxide contains roughly 60% elemental magnesium by weight, the highest of any common form. Yet in head-to-head studies, subjects taking a 196 mg organic magnesium blend showed significantly greater increases in serum and erythrocyte magnesium than those taking 450 mg of magnesium oxide. Solubility consistently outperforms raw elemental content.⁴

Chelation and Amino Acid Transport

Chelated magnesium supplements bind the mineral to an amino acid, most commonly glycine, to form a stable compound that survives gastric acid intact and is absorbed through intestinal peptide transporters rather than conventional mineral channels.⁵ This dual-pathway absorption mechanism is one reason chelated forms like magnesium bisglycinate tend to show higher relative bioavailability and fewer gastrointestinal side effects than non-chelated alternatives.⁷

The amino acid carrier also contributes its own biological activity. Glycine has N-methyl-D-aspartate (NMDA) receptor modulating properties. Taurine has cardiovascular and osmoregulatory effects. Threonate crosses the blood-brain barrier. Form selection is therefore both a bioavailability decision and a therapeutic targeting decision.

Types Of Magnesium Forms Compared: Bioavailability, Clinical Use, and Key Considerations

The table below reflects relative bioavailability of magnesium based on current evidence.^4,5,12,19 Note that direct comparisons across studies are difficult due to differences in study design, population, and outcome measures. Clinical fit, not bioavailability ranking alone, should guide form selection.

Form	Bioavailability	Laxative Effect?	Primary Clinical Applications
Glycinate / Bisglycinate	High (chelated)	No	Sleep, stress, anxiety, HPA axis support, GI-sensitive patients
Citrate	High (dose-dependent)	Mild	Muscle recovery, soreness, constipation, general repletion
Malate	Moderate to High	Minimal	Fatigue, fibromyalgia, Krebs cycle support, physical performance
L-threonate	Moderate (CNS-targeted)	No	Cognitive function, memory, sleep architecture, neurological support
Taurate	Moderate	No	Cardiovascular health, blood pressure, heart rhythm, endothelial function
Chloride	Moderate	Mild	Topical use (muscle, joint); oral repletion when GI tolerability is not a concern
Oxide	Low	Yes	Short-term constipation relief; not recommended for systemic repletion

Table 1: Relative bioavailability rankings are based on available comparative studies and may not reflect individual variability.^4,5,12,19

A Closer Look at Each Form

Magnesium Glycinate and Bisglycinate

Magnesium glycinate, or bisglycinate where two glycine molecules are attached, is among the most widely studied chelated forms and is frequently the practitioner’s first choice for managing stress, sleep disorders, and anxiety.¹⁰Metagenics offers this form in Magnesium Glycinate, formulated as magnesium bisglycinate for superior absorption and gentle digestion.

Glycine, the carrier amino acid, is itself a calming neurotransmitter. It acts as a co-agonist at NMDA receptors and has been shown to improve sleep quality and reduce core body temperature at sleep onset.^8,9These effects compound the intrinsic benefits of magnesium, which also modulates NMDA receptor activity and supports GABAergic neurotransmission.¹

Since bisglycinate is absorbed through amino acid transporters rather than mineral channels, it is particularly well-tolerated in patients with sensitive gastrointestinal tracts, inflammatory bowel conditions, or those who have experienced loose stools with other forms.^7,30 For patients who prefer a powder format or need additional nervous system support, MetaRelax^® Powder combines a bisglycinate complex with vitamins B6, folate, B12, and taurine to address the stress-magnesium connection more comprehensively.

Best for: sleep disorders, anxiety, HPA axis dysregulation, stress-related presentations, GI-sensitive patients, muscle tension

Timing: Can be taken at any time of day; often recommended in the evening for sleep and stress support

Magnesium Citrate

Magnesium citrate is one of the most commonly recommended forms for general magnesium repletion and has a well-established evidence base for supporting muscle function and recovery.¹¹ Metagenics Magnesium Citrate features a blend of magnesium citrate and calcium citrate, providing targeted support for muscle function and bone health.

Citrate’s mild osmotic laxative effect draws water into the intestinal lumen, making it a clinically useful choice for patients dealing with constipation.^3,19 This same property can become a limiting factor at higher doses, however, and taking it with food reduces the likelihood of GI discomfort.

Best for: general repletion, muscle recovery and soreness, constipation, nocturnal leg cramps, cost-effective first-line supplementation

Timing: With food to reduce GI effects; dose can be split across the day to improve tolerance

Magnesium Malate

Magnesium malate binds magnesium to malic acid, an intermediate in the citric acid cycle, which is the mitochondrial pathway through which cells generate ATP.¹³ This metabolic connection has driven interest in magnesium malate for fatigue-related presentations. A randomized controlled crossover trial found significant improvements in pain and tenderness in fibromyalgia patients supplemented with magnesium malate.¹³ MagActive^™ Magnesium Muscle Powder incorporates malic acid alongside the bisglycinate complex and electrolytes for comprehensive muscle energy support.

The evidence base is more limited than for glycinate or citrate, but the mechanistic rationale is clinically sound, particularly for patients whose primary complaint is fatigue, low energy, or exercise intolerance.

Best for: fatigue, fibromyalgia, mitochondrial support, physical performance and endurance

Timing: Morning, given its role in energy metabolism

Magnesium L-Threonate

Magnesium L-threonate, commercially available as Magtein®, is unique among magnesium forms in its demonstrated ability to cross the blood-brain barrier and elevate magnesium concentrations in cerebrospinal fluid, something other forms do not accomplish meaningfully.¹⁶ Magtein® Magnesium L-Threonate provides the clinically studied L-threonate form to support memory, attention, and healthy brain cell activity.

Clinical trials have shown improvements in memory, cognitive scores, and sleep architecture, including deep sleep and REM duration, when using L-threonate specifically. A Magtein-based formula demonstrated significant cognitive improvements in healthy adults, with more pronounced effects in older participants.¹⁵ A separate RCT found meaningful improvements in sleep quality, mood, and daytime energy compared to placebo.¹⁴

It is worth noting that L-threonate contributes less elemental magnesium per dose than most other forms. It is best understood as a neurological delivery vehicle rather than a general-purpose repletion strategy.

Best for: cognitive decline, memory support, neurological aging, sleep architecture, patients with neurological symptom burden

Timing: Evening, particularly for sleep-related outcomes

Best for: cognitive decline, memory support, neurological aging, sleep architecture, patients with neurological symptom burden

Timing: Evening, particularly for sleep-related outcomes

Best for: cognitive decline, memory support, neurological aging, sleep architecture, patients with neurological symptom burden

Timing: Evening, particularly for sleep-related outcomes

Magnesium Taurate

Magnesium taurate pairs magnesium with taurine, a conditionally essential sulfur-containing amino acid with well-documented cardiovascular and osmoregulatory activity. Taurine has been studied for its effects on endothelial function¹⁷ and blood pressure regulation.¹⁸This combination creates a synergistic profile particularly relevant for cardiovascular presentations.

Magnesium taurate is a logical consideration for practitioners working with patients who have cardiovascular concerns, hypertension, or cardiac rhythm irregularities. It is less commonly available than glycinate or citrate, and the clinical evidence base, while promising, is still developing. For patients where taurine is a desired co-ingredient, MagActive™ Magnesium Relax Powder and Endura® Electrolyte Powder both include taurine alongside magnesium bisglycinate.

Best for: cardiovascular support, hypertension, arrhythmia risk, endothelial function, metabolic syndrome

Magnesium Chloride

Magnesium chloride offers moderate oral bioavailability and is more bioavailable than magnesium oxide, though it carries a higher risk of gastrointestinal side effects, particularly loose stools, than chelated forms.¹⁹ It is also available in topical preparations, often marketed as magnesium oil or bath flakes.

The evidence for transdermal magnesium absorption remains mixed. While some practitioners report clinical benefit from topical application for localized muscle tension, data on meaningful systemic repletion via skin absorption is not robust.⁵ Topical use is a reasonable adjunct but should not replace oral supplementation in patients with known deficiency.

Best for: oral repletion where cost is a concern; topical use as an adjunct for localized muscle and joint support

Magnesium Oxide

Magnesium oxide contains the highest percentage of elemental magnesium by weight, approximately 60%, making it appear compelling on a supplement label.³ Its bioavailability is consistently among the lowest of any common form, however, and comparative studies demonstrate that organic forms with lower elemental magnesium content absorb significantly more effectively.^4,19

Magnesium oxide’s strongest clinical application is as an osmotic laxative. For patients who experience constipation and also need magnesium, it may serve both purposes simultaneously. For systemic magnesium repletion, especially in patients with established deficiency, organic forms are clearly superior.

Best for: short-term constipation relief; not recommended as a first-line choice for systemic magnesium repletion

Factors That Influence Magnesium Absorption and Retention

The form of magnesium is the most significant modifiable variable in supplement bioavailability, but several other factors shape how much magnesium the body actually absorbs and retains.

Cofactors That Support Magnesium Utilization

Vitamin D

The relationship between magnesium and vitamin D is bidirectional. Magnesium is required for the enzymatic conversion of vitamin D to its active form, calcitriol, while vitamin D helps regulate intestinal magnesium absorption.²² In patients who are replete in vitamin D but continue to show insufficiency, assessing magnesium status is a clinically appropriate next step. A RCT confirmed that subjects taking both magnesium and vitamin D showed greater increases in active vitamin D than those taking vitamin D alone.²³

Vitamin B6 (Pyridoxine)

Magnesium is primarily an intracellular mineral. Over 99% of total body magnesium is found inside cells, not in serum.⁶ Vitamin B6 appears to support intracellular magnesium retention by facilitating cellular uptake and reducing urinary excretion. Research suggests that the combination of magnesium and B6 outperforms magnesium alone for stress reduction in individuals with low magnesium status.²⁴ MetaRelax® and MagActive™ Magnesium Relax Powder both incorporate B6, folate, and B12 alongside magnesium bisglycinate to take advantage of this synergy.

Adequate Protein

Higher protein intake has been associated with improved magnesium absorption, likely through mechanisms that increase intestinal solubility.⁵ This is clinically relevant in patients who are protein-insufficient, which is another reason magnesium deficiency and protein insufficiency often co-present.

Factors That Impair Absorption or Accelerate Depletion

Phytates: found in whole grains and legumes; bind magnesium in the gut before it can be absorbed.⁵ Soaking or fermenting these foods reduces phytate content significantly.

Alcohol: increases renal magnesium excretion; heavy or chronic alcohol use is a well-established cause of magnesium depletion.²¹

Proton pump inhibitors (PPIs): reduce gastric acid, impairing dissolution of inorganic magnesium forms and reducing overall absorption with chronic use. This is an FDA-recognized drug-nutrient interaction.³

Loop and thiazide diuretics: markedly increase urinary magnesium losses. Patients on long-term diuretic therapy are at high risk of deficiency and warrant routine monitoring.²¹

High sugar and refined carbohydrate diets: increase insulin secretion, which drives magnesium into cells temporarily but also increases urinary magnesium excretion. Insulin resistance is strongly associated with hypomagnesemia, a clinically important bidirectional relationship.^20,21

Clinical Note: Insulin Resistance and Magnesium Depletion

Hypomagnesemia and insulin resistance form a self-reinforcing cycle. Low magnesium impairs insulin receptor signaling, while insulin resistance drives urinary magnesium losses. Two RCT have demonstrated that magnesium supplementation improves insulin sensitivity in subjects with insulin resistance.^20,25 Assessing magnesium status in patients with metabolic syndrome, prediabetes, or type 2 diabetes is clinically warranted.

Timing and Food

Taking magnesium with food slows gastric transit and reduces the risk of GI discomfort, particularly relevant for forms with a mild laxative effect such as citrate, chloride, and oxide.⁵ Chelated forms like bisglycinate can generally be taken with or without food and are typically better tolerated on an empty stomach than non-chelated forms. Explore the full range of Metagenics magnesium supplements to find the format and form that suits each patient’s routine.

Recognizing Magnesium Insufficiency: Why Standard Labs May Miss It

Serum magnesium is the most common laboratory measure, but it is also the least sensitive marker of magnesium status. Less than 1% of total body magnesium is found in serum; the majority is stored in bone, skeletal muscle, and soft tissue.⁶ When serum magnesium drops, the body pulls from intracellular and bone stores to maintain circulating levels, meaning serum values can appear normal long after intracellular stores are depleted.

Practitioners often describe this as chronic latent magnesium deficit, a state of tissue-level insufficiency that does not register on standard bloodwork but produces recognizable clinical symptoms.⁶ RBC magnesium testing offers a more meaningful measure of intracellular status and has been shown to correlate better with tissue magnesium levels than serum testing, though it remains underutilized in conventional settings.²⁵

Common Presentations of Magnesium Insufficiency

Muscle cramps, spasms, and twitching, particularly nocturnal leg cramps²⁸

Poor sleep quality and difficulty staying asleep²⁶

Fatigue and low energy¹

Anxiety, irritability, and low stress tolerance¹⁰

Tension headaches and migraines²¹

Low mood and emotional dysregulation¹⁰

PMS-related symptoms including cramping, mood changes, and fluid retention²⁷

Elevated blood pressure and cardiac arrhythmia in more significant deficiency²¹

Populations at Highest Risk

Older adults: intestinal magnesium absorption declines with age and renal conservation is also reduced²

Individuals with type 2 diabetes or insulin resistance: increased urinary magnesium losses are well documented^20,21

Those with inflammatory GI conditions: Crohn’s disease, celiac disease, and short bowel syndrome reduce absorptive capacity³

Patients on long-term PPIs or diuretics: drug-nutrient interaction is an FDA-recognized concern for PPIs specifically³

Athletes and high-volume exercisers: increased losses through sweat and elevated metabolic demand; may benefit from electrolyte formulas such as Endura® Electrolyte Powder²⁹

Choosing the Right Magnesium Form for Your Patient

For most adults without significant complicating factors, the form of magnesium that best supports the primary health goal is the right starting point. The table below provides a practical clinical reference, recognizing that patient presentations often involve more than one concern.

Clinical Goal	Recommended Form(s)	Rationale and Metagenics Product
Sleep and stress	Glycinate / Bisglycinate	Glycine modulates NMDA receptors⁸, supports GABAergic tone¹; GI-gentle. See: Magnesium Glycinate
Anxiety and HPA axis support	Glycinate / Bisglycinate	Stress drives urinary Mg losses¹⁰; Mg modulates cortisol and HPA axis reactivity. See: MagActive™ Relax Powder
Muscle recovery and soreness	Citrate or Glycinate	Citrate has direct RCT evidence for DOMS reduction¹¹; glycinate for patients requiring better GI tolerance. See: Magnesium Citrate
Muscle tension and relaxation	Glycinate with botanicals	Mg with passionflower and valerian targets skeletal muscle relaxation and sleep disturbance. See: MyoCalm® or MyoCalm® Plus
Fatigue and energy	Malate	Malic acid is a direct Krebs cycle intermediate¹³; studied in fibromyalgia and exercise intolerance. See: MagActive™ Muscle Powder
Cognitive function and memory	L-threonate (Magtein®)	Only form shown to elevate cerebrospinal fluid Mg16; clinical trials show memory and cognitive improvements¹⁵. See: Magtein® Magnesium L-Threonate
Sleep architecture and circadian rhythm	Glycinate with saffron and passionflower	Mg supports melatonin pathway²⁶; Affron® saffron enhances melatonin production. See: MagActive™ Night Powder
Cardiovascular and blood pressure	Taurate	Taurine supports endothelial function¹⁷ and blood pressure regulation¹⁸ synergistic with Mg’s membrane-stabilizing effects
PMS and hormonal symptoms	Glycinate or Citrate	RCT evidence supports Mg for PMS-related mood changes and cramping²⁷
Nocturnal leg cramps	Magnesium Citrate	RCT demonstrates Mg citrate reduces chronic persistent leg cramps²⁸ See: Magnesium Citrate
Insulin resistance and metabolic health	Glycinate or Citrate	Mg supplementation improves insulin sensitivity in subjects with insulin resistance^20,25
Hydration and athletic recovery	Bisglycinate with electrolytes	Mg as electrolyte supports fluid balance, nerve conduction, and endurance performance²⁹ See: Endura® Electrolyte Powder
General repletion, cost-sensitive	Citrate	Well-absorbed organic form, widely available, strong evidence base^4,19 See: Magnesium Citrate

Table 2: Magnesium form selection should be guided by clinical indication, as different forms offer targeted physiological and therapeutic benefits across systems.

For patients with multiple goals or complex presentations, multi-form blends can provide broader coverage. MagActive™ Magnesium Night Powder combines magnesium complex with Affron® saffron and passionflower to address sleep, stress, and muscle tension simultaneously. Some practitioners use different forms at different times of day, for example malate in the morning for energy support and bisglycinate in the evening for sleep.

For patients who need muscular relaxation alongside botanical support, MyoCalm® and MyoCalm® Plus combine magnesium citrate with combos of passionflower, valerian, lemon balm, and hops, and are particularly well-suited to patients with sleep disruption tied to physical stress or musculoskeletal discomfort.

Dosage, Safety, and Clinical Considerations

Recommended Dietary Allowance (RDA)

The RDA for magnesium is 400 to 420 mg per day for adult males and 310 to 320 mg per day for adult females, with values up to 400 mg per day during pregnancy. These figures represent total intake from food and supplements combined.³

Elemental Magnesium vs. Salt Weight

Supplement labels list elemental magnesium, not the total weight of the compound. This distinction matters because magnesium oxide is roughly 60% elemental magnesium by weight, while bisglycinate may be closer to 14 to 20% depending on the specific formulation.⁴ To read a magnesium label accurately, look at the Supplement Facts panel rather than the front-of-label claim. The milligram amount listed next to “Magnesium” is the elemental magnesium content. The notation in parentheses, such as “as magnesium bis-glycinate,” identifies the form. The percentage listed in the % Daily Value column reflects what that elemental amount represents relative to the recommended daily intake, not the purity or concentration of the compound.

For example, the Metagenics Magnesium Glycinate label (Figure 1) reads: Magnesium 100 mg (as magnesium bis-glycinate) – 24% Daily Value. This means each tablet delivers 100 mg of elemental magnesium, which represents 24% of the general reference daily intake. The total weight of the bisglycinate compound in that tablet is considerably higher than 100 mg, but only 100 mg is actual magnesium. A product marketed as “500 mg magnesium bisglycinate” on its front label may contain far less elemental magnesium than that figure suggests. Always verify the elemental amount on the Supplement Facts panel before comparing products or calculating dose.

Figure 1: Metagenics Magnesium Glycinate supplement facts panel showing 100 mg elemental magnesium as magnesium bis-glycinate per tablet, representing 24% of the daily value.

Supplemental Upper Limit

The tolerable upper intake level (UL) for supplemental magnesium is 350 mg per day for adults. This applies to supplemental forms only; dietary magnesium from food does not pose a risk of adverse effects in healthy individuals.³ Exceeding the supplement UL may cause osmotic diarrhea, nausea, and cramping; very high doses can cause hypotension and cardiac dysrhythmia, particularly in individuals with impaired renal function.

Renal Considerations

The kidneys are the primary route of magnesium excretion. In individuals with chronic kidney disease or significantly reduced GFR, supplemental magnesium requires clinical supervision.³ Impaired kidneys cannot excrete excess magnesium efficiently, raising the risk of hypermagnesemia.

Drug and Nutrient Interactions

Antibiotics (quinolones and tetracyclines): magnesium chelates these drugs, reducing their absorption. Separate administration by at least 2 hours.³

Bisphosphonates: magnesium reduces absorption; administer at least 2 hours apart.³

Loop and thiazide diuretics: deplete magnesium; concurrent monitoring and supplementation are frequently indicated.²¹

Proton pump inhibitors: chronic use is an FDA-recognized cause of hypomagnesemia; monitoring magnesium in long-term PPI users is appropriate.³

Calcineurin inhibitors (tacrolimus and cyclosporine): commonly cause hypomagnesemia as a known adverse effect; supplementation is often necessary in transplant populations.

The Right Form for the Right Person

The framing of “best absorbed form of magnesium” misses a key clinical point. Each form brings something distinct to the table. Bioavailability is one important variable, but therapeutic targeting, specifically what the carrier molecule does, where it goes, and which physiological pathways it supports, matters just as much in clinical decision-making.

Three questions should guide form selection:

What is the primary therapeutic goal? Sleep, cardiovascular support, cognitive function, energy, and constipation each point toward different forms and formulations.

What is the patient’s GI tolerability? Chelated forms are preferable for patients with sensitive GI tracts or a history of loose stools with magnesium.

Are there complicating factors? Kidney disease, medication use, and specific health conditions may affect form choice, dosing strategy, and the need for monitoring.

The Metagenics magnesium platform offers targeted solutions across these clinical needs. Explore the full range HERE. When in doubt, encourage patients to work with a qualified healthcare practitioner who can assess magnesium status, review the full clinical picture, and guide selection of the form and dose most appropriate for their individual needs.

ABOUT THE AUTHOR

Dr. Malisa Carullo, ND is a naturopathic doctor and serves as Senior Manager of Medical Information and Safety at Metagenics, where she supports clinical education, product safety, and evidence-based practitioner guidance across North America.

She holds a Doctorate in Naturopathic Medicine and a Master of Science in Biology, with a focus on chronic disease care, healthy aging, and evidence-based approaches to long-term wellness. Dr. Carullo is dedicated to empowering both practitioners and patients through clear, research-informed education that bridges science and everyday health decisions.

References

Souza et al. Nutrients. 2023;15(24):5127.
Razzaque MS. Nutrients. 2018;10(12):1863.
National Institutes of Health Office of Dietary Supplements. Magnesium Fact Sheet for Health Professionals. 2024.
Blancquaert L et al. Nutrients. 2019;11(7):1663.
Schuchardt JP et al. Curr Nutr Food Sci. 2017;13(4):260–278.
Workinger JL et al. Nutrients. 2018;10(9):1202.
Vynckier AK et al. J Nutr Food Sci. 2020;10(5):1–4.
Kawai N et al. Neuropsychopharmacology. 2015;40(6):1405–1416.
Bannai M et al. J Pharmacol Sci. 2012;118(2):145–148.
Pickering G et al. Nutrients. 2020;12(12):3672.
Tarsitano MG et al. J Transl Med. 2024;22(1):629.
Rylander R. J Pharm Nutr Sci. 2014;4(1):57–59.
Russell IJ et al. J Rheumatol. 1995;22(5):953–958.
Hausenblas HA et al. Sleep Med X. 2024;8:100121.
Zhang C et al. Nutrients. 2022;14(24):5235.
Slutsky I et al. Neuron. 2010;65(2):165–177.
Katakawa M et al. Hypertens Res. 2016;39(12):848–856.
Kass L et al. Eur J Clin Nutr. 2012;66(4):411–418.
Pardo MR et al. Nutrition. 2021;89:111294.
Guerrero-Romero F et al. Diabetes Metab. 2004;30(3):253–258.
Fritzen R et al. Nutrients. 2023;15(10):2355.
Uwitonze AM et al. J Am Osteopath Assoc. 2018;118(3):181–189.
Cheung MM et al. Nutrition. 2022;99–100:111674.
Pouteau E et al. PLoS One. 2018;13(12):e0208454.
Rodriguez-Moran M et al. Diabetes Care. 2003;26(4):1147–1152.
Abbasi B et al. J Res Med Sci. 2012;17(12):1161–1169.
Facchinetti F et al. Obstet Gynecol. 1991;78(2):177–181.
Roffe C et al. Med Sci Monit. 2002;8(5):CR326–330.
Rodriguez NR et al. J Am Diet Assoc. 2009;109(3):509–527.
Schuette SA et al. JPEN J Parenter Enteral Nutr. 1994;18(5):430–435.